Cargando…
Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study
PURPOSE: Oral bisphosphonates (BPs) are the most commonly used medications for osteoporosis (OP), but their poor gastrointestinal (GI) absorption and tolerance hamper compliance. Intramuscular (IM) neridronate (NE), an amino-BP, is an easy-to-administer, effective, and safe alternative to oral BPs....
Autores principales: | Guiducci, L., Vassalle, C., Parchi, P., Maffei, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381585/ https://www.ncbi.nlm.nih.gov/pubmed/30881452 http://dx.doi.org/10.1155/2019/9802827 |
Ejemplares similares
-
Neridronate for transient osteoporosis of the hip in a child
por: Gaggiano, C., et al.
Publicado: (2022) -
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012) -
Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study
por: Aloumanis, K., et al.
Publicado: (2011) -
Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).
por: O'Rourke, N. P., et al.
Publicado: (1994) -
Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013)